awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55310350-2037E4A6-5A6E-46E5-A76B-C7947B28F7D6
Q55310350-2037E4A6-5A6E-46E5-A76B-C7947B28F7D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55310350-2037E4A6-5A6E-46E5-A76B-C7947B28F7D6
Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.
P2860
Q55310350-2037E4A6-5A6E-46E5-A76B-C7947B28F7D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55310350-2037E4A6-5A6E-46E5-A76B-C7947B28F7D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2fad279b1095e28298e4cc4d7f90bff421dcb708
P2860
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.